These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 26609488)
1. The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target. Wong M; Polly P; Liu T Am J Cancer Res; 2015; 5(9):2823-37. PubMed ID: 26609488 [TBL] [Abstract][Full Text] [Related]
2. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465 [TBL] [Abstract][Full Text] [Related]
3. The upstreams and downstreams of H3K79 methylation by DOT1L. Vlaming H; van Leeuwen F Chromosoma; 2016 Sep; 125(4):593-605. PubMed ID: 26728620 [TBL] [Abstract][Full Text] [Related]
4. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment. Sarno F; Nebbioso A; Altucci L Epigenetics; 2020 May; 15(5):439-453. PubMed ID: 31790636 [TBL] [Abstract][Full Text] [Related]
5. A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L. Anglin JL; Song Y J Med Chem; 2013 Nov; 56(22):8972-83. PubMed ID: 23879463 [TBL] [Abstract][Full Text] [Related]
6. The emerging roles of DOT1L in leukemia and normal development. McLean CM; Karemaker ID; van Leeuwen F Leukemia; 2014 Nov; 28(11):2131-8. PubMed ID: 24854991 [TBL] [Abstract][Full Text] [Related]
8. The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle. Kim W; Choi M; Kim JE Cell Cycle; 2014; 13(5):726-38. PubMed ID: 24526115 [TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth. Wu F; Nie S; Yao Y; Huo T; Li X; Wu X; Zhao J; Lin YL; Zhang Y; Mo Q; Song Y Theranostics; 2021; 11(17):8172-8184. PubMed ID: 34373735 [TBL] [Abstract][Full Text] [Related]
10. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness. Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689 [TBL] [Abstract][Full Text] [Related]
11. DOT1L and H3K79 Methylation in Transcription and Genomic Stability. Wood K; Tellier M; Murphy S Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29495487 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Bon C; Si Y; Pernak M; Barbachowska M; Levi-Acobas E; Cadet Daniel V; Jallet C; Ruzic D; Djokovic N; Djikić T; Nikolic K; Halby L; Arimondo PB Molecules; 2021 Aug; 26(17):. PubMed ID: 34500733 [TBL] [Abstract][Full Text] [Related]
13. The diverse functions of Dot1 and H3K79 methylation. Nguyen AT; Zhang Y Genes Dev; 2011 Jul; 25(13):1345-58. PubMed ID: 21724828 [TBL] [Abstract][Full Text] [Related]
14. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer. Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761 [TBL] [Abstract][Full Text] [Related]
15. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential. Kuntimaddi A; Achille NJ; Thorpe J; Lokken AA; Singh R; Hemenway CS; Adli M; Zeleznik-Le NJ; Bushweller JH Cell Rep; 2015 May; 11(5):808-20. PubMed ID: 25921540 [TBL] [Abstract][Full Text] [Related]
16. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620 [TBL] [Abstract][Full Text] [Related]
17. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. Kim W; Kim R; Park G; Park JW; Kim JE J Biol Chem; 2012 Feb; 287(8):5588-99. PubMed ID: 22190683 [TBL] [Abstract][Full Text] [Related]
19. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development. Barry ER; Corry GN; Rasmussen TP Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194 [TBL] [Abstract][Full Text] [Related]
20. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia. Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ Cells; 2019 Oct; 8(11):. PubMed ID: 31717699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]